Perfil
Dr. René Muttenzer is on the Board of Directors at Polyphor AG and Molecular Health AG.
Dr. Muttenzer was previously employed as a Principal by Novartis AG.
He also served on the board at Acino Holding AG.
He received his graduate degree from the University of Basel.
Antiguos cargos conocidos de René Muttenzer.
Empresas | Cargo | Fin |
---|---|---|
ACINO HOLDING AG | Director/Miembro de la Junta | 31/03/2012 |
NOVARTIS AG | Corporate Officer/Principal | - |
Posbelduf Biotech AG
Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Director/Miembro de la Junta | - |
SPEXIS AG | Director/Miembro de la Junta | - |
Formación de René Muttenzer.
University of Basel | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
SPEXIS AG | Health Technology |
NOVARTIS AG | Health Technology |
Empresas privadas | 2 |
---|---|
Acino International AG
Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Posbelduf Biotech AG
Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- René Muttenzer